Aster DM Healthcare Q4 Revenue Up 18% YoY

Aster DM Healthcare reported Q4FY26 revenue of INR 1,182 Cr, an 18% YoY growth, with Operating EBITDA up 26% to INR 244 Cr.
The proposed merger with QCIL received 96.68% shareholder approval, with a combined proforma entity showing 18% YoY revenue growth to INR 2,361 Cr in Q4FY26.
Operational highlights include a 12% YoY growth in combined patient volumes to 1.93 Mn and the addition of 290 beds, taking total capacity to 5,449 beds.
Management provided a strategic outlook focusing on bed expansion, with 2,728 new beds planned, and expects the QCIL merger to complete in Q1FY27.